Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase Intra-Arterial Bridging Thrombolysis After Incomplete Recanalization in Acute Large Vessel Occlusion Stroke
ChiCTR2500108980Phase 4Recruiting
- Sponsor
- Baotou Central Hospital
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by Baotou Central Hospital. Primary endpoints: Proportion of patients with 90-day mRS 0-1, All-cause mortality at 90 days and 1 more. Started Sep 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500108980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108980.